1,3-dipropyl-8-cyclopentylxanthine has been researched along with isoflurane in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gross, GJ; Kersten, JR; Mei, DA; Orth, KG; Pagel, PS; Warltier, DC | 1 |
| Foëx, P; Kato, R; Yao, L | 1 |
| Chen, S; Liu, Y; Wang, Q; Xiong, L | 1 |
3 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and isoflurane
| Article | Year |
|---|---|
Role of adenosine in isoflurane-induced cardioprotection.
Topics: Anesthetics, Inhalation; Animals; Dogs; Hemodynamics; Isoflurane; Myocardial Reperfusion Injury; Purinergic P1 Receptor Antagonists; Xanthines | 1997 |
Isoflurane-induced protection against myocardial stunning is independent of adenosine 1 (A(1)) receptor in isolated rat heart.
Topics: Anesthetics, Inhalation; Animals; Diastole; Isoflurane; Male; Myocardial Contraction; Myocardial Stunning; Organ Culture Techniques; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Xanthines | 2001 |
Isoflurane tolerance against focal cerebral ischemia is attenuated by adenosine A1 receptor antagonists.
Topics: Adenosine A1 Receptor Antagonists; Anesthetics, Inhalation; Animals; Brain Ischemia; Ischemic Preconditioning; Isoflurane; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Xanthines | 2006 |